# Clinical Utility of VI-RADS in Diagnosis of MIBC

> **NCT05097404** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 73 (estimated)

## Conditions studied

- Radical Cystectomy
- Muscle-Invasive Bladder Carcinoma
- Multiparametric MRI
- Vesical Imaging Report and Data System

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05097404
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-09
- **Primary completion:** 2024-09
- **Final completion:** 2024-09
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05097404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05097404, "Clinical Utility of VI-RADS in Diagnosis of MIBC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05097404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*